News
-
-
-
PRESS RELEASE
Xlife Sciences AG Delivers Breakthrough in Early Alzheimer’s Detection, Unlocking Major Market Opportunity
Xlife Sciences AG and saniva diagnostics GmbH announce NeuroMex, the world's first certified medical device for early Alzheimer's detection, with 83.5% accuracy in identifying early-stage Alzheimer's -
-
-
PRESS RELEASE
Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process Following U.S. Government Shutdown
Xlife Sciences AG updates on VERAXA Biotech AG's NASDAQ listing process post U.S. Government Shutdown, SEC responds to Form F-4 filing, progress towards business combination with Voyager Acquisition Corp -
-
-
-